JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202553200 on May 13, 2002

J. Biol. Chem., Vol. 277, Issue 29, 25870-25876, July 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/29/25870    most recent
M202553200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovett, J. L.
Right arrow Articles by Sibley, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovett, J. L.
Right arrow Articles by Sibley, L. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Toxoplasma gondii Microneme Secretion Involves Intracellular Ca2+ Release from Inositol 1,4,5-Triphosphate (IP3)/Ryanodine-sensitive Stores*

Jennie L. LovettDagger §, Norma Marchesini, Silvia N. J. Moreno||, and L. David SibleyDagger **

From the Dagger  Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110 and the  Laboratory of Molecular Parasitology, Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois 61802

Received for publication, March 15, 2002, and in revised form, May 7, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Calcium-mediated microneme secretion in Toxoplasma gondii is stimulated by contact with host cells, resulting in the discharge of adhesins that mediate attachment. The intracellular source of calcium and the signaling pathway(s) triggering release have not been characterized, prompting our search for mediators of calcium signaling and microneme secretion in T. gondii. We identified two stimuli of microneme secretion, ryanodine and caffeine, which enhanced release of calcium from parasite intracellular stores. Ethanol, a previously characterized trigger of microneme secretion, stimulated an increase in parasite inositol 1,4,5-triphosphate, implying that this second messenger may mediate intracellular calcium release. Consistent with this observation, xestospongin C, an inositol 1,4,5-triphosphate receptor antagonist, inhibited microneme secretion and blocked parasite attachment and invasion of host cells. Collectively, these results suggest that T. gondii possess an intracellular calcium release channel with properties of the inositol 1,4,5-triphosphate/ryanodine receptor superfamily. Intracellular calcium channels, previously studied almost exclusively in multicellular animals, appear to also be critical to the control of parasite calcium during the initial steps of host cell entry.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Apicomplexans are unicellular parasites that must enter cells to replicate. Members of this phylum share a common vulnerability when the process of invasion is compromised, yet diseases caused by apicomplexans remain among the most difficult to cure. The invasion process is rapid and marked by the sequential secretion of parasite organelles. Micronemes, rhoptries, and dense granule contents are released by invading parasites and participate in attachment, vacuole formation, and intracellular survival (1). Understanding the mechanisms regulating parasite secretion could thus be useful in the design of new therapeutic strategies aimed at blocking invasion.

Micronemes are the first secretory organelles to be discharged during Toxoplasma gondii invasion. Microneme proteins possess a variety of adhesive domains and include soluble and transmembrane forms (2, 3). Their release appears highly regulated in that host cell contact triggers a burst of microneme release (1). Binding studies suggest that microneme proteins participate in attachment to host cell surfaces (4-7) and that the transmembrane form of the adhesin MIC2 may link parasite and host cell membranes during invasion.

Previous studies demonstrated that increases in intracellular calcium ([Ca2+]i) mediate microneme secretion in T. gondii. For example, association of T. gondii tachyzoites with host cells results in increases in parasite [Ca2+]i (8) and chelation of T. gondii [Ca2+]i blocks microneme secretion and invasion (9). Moreover, reagents that raise T. gondii [Ca2+]i levels stimulate microneme discharge in the absence of host cells (10). These include Ca2+ ionophores ionomycin and A23187, as well as the sarco-endoplasmic reticulum ATPase inhibitor thapsigargin (10). Identification of alcohols as potent artificial triggers of microneme secretion led to studies demonstrating that ethanol also raises parasite [Ca2+]i levels (11). T. gondii possess several intracellular stores of Ca2+, including the acidocalcisomes (12), mitochondria, and the endoplasmic reticulum (13). Whether all or some of these stores participate in microneme secretion during host cell invasion is unknown. The mechanism of Ca2+-mediated microneme release in both artificially triggered and natural microneme secretion during invasion remains largely undefined.

Regulated exocytosis is associated with fluxes in [Ca2+]i, although the exact step requiring Ca2+ is unclear and may depend on the system being studied (14). Ca2+ signaling involves the mobilization of Ca2+ from two sources: intracellular stores and the extracellular medium. In mammalian cells, the sarco-endoplasmic reticulum is a commonly utilized source of readily accessible [Ca2+]i, which can be rapidly mobilized under a variety of stimuli. Two types of sarco-endoplasmic reticulum Ca2+ release channels have been identified in multicellular animals: the IP31 receptor and the ryanodine receptor, which are structurally similar and are thought to be evolutionarily related (15). Binding of the second messenger IP3 to its receptor releases Ca2+ into the cytosol, whereas ryanodine receptors are modulated in some cells by cyclic ADP-ribose (16). This release of intracellular Ca2+ can in some manner signal the activation of Ca2+ entry, a process known as capacitative Ca2+ entry (17).

Neither IP3, ryanodine receptors, or capacitative Ca2+ entry have been identified in unicellular organisms, including yeast and protozoa. However, evidence linking IP3 to [Ca2+]i flux has been described in several unicellular systems. Treatment of membrane vesicles from Candida albicans (18) or Plasmodium chabaudi (19) with IP3 results in Ca2+ release and is blocked by the IP3 receptor antagonist heparin. IP3 induces Ca2+ release from Euglena gracilis microsomes in a dose-dependent manner (20). Carbachol stimulation of Trypanosoma cruzi results in increased [Ca2+]i and IP3 (21). In characean algae, introduction of IP3 produces action potentials, an event known to involve increases in cytoplasmic Ca2+ (22). Collectively, these studies indicate a potential role for IP3 in Ca2+-mediated signaling events among early branching unicellular eukaryotes.

We were interested in determining whether IP3 functions as a mediator of microneme secretion by increasing parasite [Ca2+]i. In this work, we present evidence that T. gondii may possess intracellular release channels of the IP3/ryanodine receptor superfamily.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals-- Caffeine, EGTA, and ryanodine were purchased from Sigma. BAPTA-AM and xestospongin C were purchased from Calbiochem. The BiotrakTM [3H]IP3 assay system was purchased from Amersham Biosciences. All other reagents were analytical grade. Drugs were resuspended as 100× stock solutions in either distilled water or Me2SO.

Parasite Culture-- T. gondii strain RH and the lacZ-expressing clone 2F were maintained as tachyzoites in human foreskin fibroblast cells as described (23). For Ca2+ measurement experiments, RH tachyzoites were maintained in bovine turbinate cells (ATCC CRL 1390) (12). All experiments used freshly lysed out parasites purified by passage through a 23-gauge needle and filtration through a 3 micron Nucleopore membrane. All cultures tested free of Mycoplasma using the GenProbeTM mycoplasma detection system.

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting-- SDS-PAGE was performed in 7% mini-gels under reducing conditions and transferred to nitrocellulose as previously described (10). Western blotting was performed with mouse anti-TgMIC2 monoclonal antibody 6D10 (ascites, 1:10,000) (10), mouse anti-TgMIC4 monoclonal antibody 5B1 (supernatant, 1:10) (24), and rabbit polyclonal anti-TgACT1 actin antibody (1:10,000) (25). Mouse anti beta -galactosidase monoclonal antibody 40-1a (supernatant, 1:50) was a gift from Dr. Joshua Sanes (University of Washington, Seattle, WA).

IP3 Quantification-- Tachyzoites were resuspended at 3 × 109/ml in 10 mM HEPES, 1 mM EGTA in Hanks' balanced salt with no calcium chloride, magnesium chloride, magnesium sulfate, or sodium bicarbonate and split into two tubes. After equilibration at 37 °C for 5 min, secretagogues or a solvent control were added (time 0). At 30-60 s intervals 0.1 ml of parasites were removed and added to an equal volume of ice-cold 15% trichloroacetic acid. Tubes were vortexed and spun at 4 °C for 15 min at 2000 × g. Supernatants were extracted three times with 10 volumes of water-saturated ether and adjusted to pH 7.5 with 1 M sodium bicarbonate. Pellets were resuspended in SDS-PAGE sample buffer for confirmation of secretion stimulation by Western blotting of TgMIC2. IP3 in ether-extracted supernatants was measured in duplicate based on the potential of the parasite samples containing IP3 to displace [3H]IP3 from a bovine IP3 receptor as described in the Amersham BiotrakTM protocol. Basal levels of IP3 ranged from 0.4 to 0.6 pmol/108 parasites.

Microneme Secretion Assay-- Tachyzoites were resuspended at 108/ml in Dulbecco's modified Eagle's medium, 1% fetal bovine serum, and 20 mM HEPES, pH 7.5 at 18 °C in 1.5 ml microcentrifuge tubes. Pretreatment with stock solutions of drugs proceeded for 15 min before transferring parasites to 37 °C for 2 min to stimulate secretion followed by transfer to a wet ice bath. In parallel, 100 µM BAPTA-AM was loaded for 10 min at 18 °C, while 10 mM EGTA was added immediately prior to secretagogue stimulation to minimize leaching of intracellular Ca2+ stores. Parasite supernatants were separated from pellets by centrifugation at 4 °C and run on 7% SDS-PAGE gels next to pellet dilutions to indicate the secreted and cellular forms of TgMIC2. Inadvertent lysis of parasites was monitored by the release of constitutively expressed beta -galactosidase in clone 2F or actin in strain RH.

Measurement of Parasite [Ca2+]i-- After being harvested, tachyzoites were washed twice at 500 × g for 10 min at room temperature in buffer A (116 mM NaCl/5.4 mM KCl/0.8 mM MgSO4/5.5 mM D-glucose/50 mM HEPES, pH 7.4). Parasites were resuspended to a final density of 109 cells/ml in loading buffer, which consisted of buffer A plus 1.5% (w/v) sucrose and 6 µM fura-2/AM. The suspensions were incubated for 30 min at 25 °C. Subsequently, the cells were washed twice with buffer A to remove extracellular dye. Parasites were resuspended to a final density of 109 cells/ml in buffer A and kept in ice. Parasites were viable for several hours under these conditions. For fluorescence measurements, a 50-µl aliquot of the cell suspension was diluted into 2.5 ml of buffer A (2 × 107 cells/ml final density) in a cuvette placed into a Hitachi F-2000 spectrofluorometer at room temperature. For measurements with fura-2, excitation was at 340 and 380 nm and emission was at 510 nm. The fura-2 fluorescence response to [Ca2+]i was calibrated from the ratio of fluorescence values at 340 and 380 nm after subtraction of the background fluorescence of the cells at 340 and 380 nm. [Ca2+]i was calculated by titration with different concentrations of Ca2+/EGTA buffers. Traces shown are representative of at least three independent experiments conducted on separate cell preparations. Variations in the values of [Ca2+]i between experiments with different cell preparations were less than 20%.

Attachment and Invasion Assays-- Tachyzoite invasion of human foreskin fibroblasts grown to confluence in 24-well plates was quantified by colorimetric detection of beta -galactosidase expressed by strain 2F as previously described (25). To assess the effects of drugs on attachment, plates were fixed with 2.5% (w/v) formaldehyde for 20 min at 4 °C, washed three times with complete media (Dulbecco's modified Eagle's medium, 10% FBS, 10 mM HEPES, 2 mM glutamine, 20 µg/ml gentamicin), and then equilibrated at 37 °C with complete media. This fixation protocol prevents the majority of parasites from invading while still allowing adhesion to occur. Parasites were resuspended at 107/ml in invasion medium and treated for 10 min at room temperature with stock solutions of drugs. Treated parasites were added in 0.2 ml volume to warm 24-well plates of human foreskin fibroblasts in quadruplicate and incubated for 20 min at 37 °C for both assays.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ryanodine Stimulates Ca2+-mediated Microneme Secretion-- Ryanodine has been shown to mediate increases in [Ca2+]i in a variety of multicellular organisms (26). To determine whether ryanodine stimulated Toxoplasma microneme secretion, we treated tachyzoites with ryanodine at concentrations ranging from 1 nM to 100 µM, removed the cells by centrifugation, and examined secreted proteins MIC2 and MIC4 present in supernatants by Western blotting. MIC2 is a convenient marker for microneme secretion because the secreted 95-100-kDa form (sMIC2) is released into supernatants, while the cell-associated 115-kDa form (cMIC2) remains in the parasite pellet (27). Similarly, the secreted form of MIC4 is 70-kDa, while cell-associated MIC4 is 72 kDa. Constitutive expression of beta -galactosidase in the 2F strain was used to control for inadvertent lysis of the parasites during the experiment and was typically between 1-5%, as indicated by comparison with dilutions of a parasite cell standard (% cell stds).

Secretion of MIC2 and MIC4 was stimulated by ryanodine at doses from 1 nM to 10 µM but inhibited at 100 µM when compared with parasites treated with Me2SO (Fig. 1A). The inhibition of microneme secretion at 100 µM is consistent with previous studies indicating that high doses keep the ryanodine receptor in a closed conformation (26). To determine whether ryanodine stimulation of microneme secretion involved an increase of [Ca2+]i from either intracellular stores or the extracellular medium, we pretreated parasites with the membrane-permeable calcium chelator BAPTA-AM to prevent [Ca2+]i increases (8) or added EGTA to the parasites immediately prior to addition of ryanodine to chelate extracellular Ca2+ and prevent Ca2+ entry (12). BAPTA-AM pretreatment inhibited microneme secretion upon stimulation with 100 nM ryanodine (Fig. 1A), indicating that ryanodine-mediated secretion required a rise in parasite [Ca2+]i. Additionally, EGTA also blocked ryanodine stimulation of microneme secretion, showing that extracellular Ca2+ was required by the parasite. Monitoring of [Ca2+]i using fura-2-loaded parasites confirmed these results. The increase in [Ca2+]i produced by ryanodine in the absence of extracellular Ca2+ (with 1 mM EGTA added to the incubation medium; Fig. 1B, +EGTA) confirmed the hypothesis that ryanodine is able to release Ca2+ from intracellular stores of T. gondii. Under these conditions [Ca2+]i rapidly decreased, probably through Ca2+ efflux to the external medium or Ca2+ uptake into other intracellular stores. In the presence of extracellular Ca2+ a greater and sustained response was observed upon addition of ryanodine (Fig. 1B). Both the magnitude and duration of this elevated [Ca2+]i response were greater in the presence of extracellular Ca2+ (Fig. 1B). This sustained [Ca2+]i elevation in the presence of extracellular Ca2+ could be due either to capacitative Ca2+ entry (17) or to inhibition of Ca2+ efflux by ryanodine as has been postulated to occur in smooth muscle cells (28). Because treatment of tachyzoites with EGTA prevented microneme secretion (Fig. 1A) a sustained [Ca2+]i increase is apparently responsible for this process.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Ryanodine affects calcium-mediated microneme secretion and increases intracellular calcium. A, Western blot of parasite supernatants following treatment with RYA compared with diluted lysates of parasite cell standards (cell stds). Secretion of MIC2 and MIC4 was stimulated by 1 nM to 10 µM ryanodine, but was inhibited at 100 µM. Tachyzoites were pretreated with the Ca2+ chelator BAPTA-AM (100 µM) or 10 mM EGTA immediately prior to treatment with ryanodine as above. Identical blots were probed with monoclonal antibody 6D10 (cellular MIC2 (cMIC2) and secreted MIC2 (sMIC2); upper panel), 40a-1 mouse anti-beta -galactosidase (beta -gal; lower panel), and 5B1 mouse anti-MIC4 (MIC4; lower panel). beta -galactosidase is a cytoplasmic protein used to indicate parasite lysis. The low molecular weight band visible in the 100% pellet standard is a degradation product. B, intracellular calcium measurements of fura-2/AM-loaded tachyzoites. Ryanodine stimulated a greater increase in tachyzoite [+Ca2+]i in the presence of extracellular +Ca2+ (+Ca2+) than in a minimal Ca2+ buffer (+EGTA). Parasite [+Ca2+]i was monitored in the presence of 1 mM EGTA (+EGTA) or 1 mM CaCl2 (+Ca2+); 1 µM ryanodine was added where indicated by the arrow. Lowest trace reflects untreated parasite [Ca2+]i levels.

Caffeine Stimulates Ca2+-mediated Microneme Secretion-- Caffeine is a pharmacological agonist of ryanodine receptor Ca2+ release (26). Based on the above evidence that T. gondii has a ryanodine-sensitive Ca2+ response, we tested caffeine for its ability to stimulate microneme secretion. Tachyzoites were incubated with caffeine at concentrations ranging from 1 µM to 1 mM before collection of supernatants for analysis by Western blot. Caffeine stimulated microneme secretion at all doses, while only causing minimal parasite lysis (Fig. 2A). Additionally, BAPTA-AM pretreatment to prevent parasite [Ca2+]i increase (8) abrogated caffeine-induced microneme secretion, indicating that a rise in [Ca2+]i was required for caffeine's effect. Unlike ryanodine, caffeine's ability to stimulate microneme secretion did not require extracellular Ca2+, as chelation with EGTA prior to addition of caffeine did not affect secretion of TgMIC2 and TgMIC4 (Fig. 2A).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Caffeine stimulates microneme secretion and parasite intracellular calcium. A, Western blot of parasite supernatants following treatment with caffeine (CAFF) compared with diluted lysates of parasite cell standards (cell stds) was performed as in the legend to Fig. 1. 1 µM-1 mM caffeine-stimulated dose-dependent secretion of MIC2 and MIC4. B, intracellular calcium measurements of fura-2/AM-loaded tachyzoites. Tachyzoites loaded with fura-2/AM as described under "Experimental Procedures," were incubated in buffer A; traces were made in the presence of 1 mM EGTA or 1 mM CaCl2 (Ca2+); the arrow indicates the point of addition of 1 mM caffeine (CAFF).

Caffeine treatment also increased parasite [Ca2+]i, as shown by direct monitoring of Ca2+ using fura-2-loaded tachyzoites (Fig. 2B). Unlike ryanodine, caffeine resulted in a more sustained [Ca2+]i increase in the absence of extracellular Ca2+. The lack of inhibition of microneme secretion by addition of EGTA could be related to either this more sustained response or to a closer spatial association between the caffeine-sensitive channels and the micronemes. Collectively, these results indicate that caffeine increased [Ca2+]i, which in turn stimulated microneme secretion in T. gondii.

Toxoplasma appears very sensitive to the effects of caffeine, as stimulation of secretion was observed down to micromolar levels while this compound is typically used at millimolar doses in other systems (29). Caffeine has at least two major effects on mammalian cells: stimulation of ryanodine receptor-mediated Ca2+ release and inhibition of cyclic nucleotide phosphodiesterases (reviewed in Ref. 29). To address the possibility that caffeine stimulated microneme secretion through inhibition of cyclic nucleotide phosphodiesterases, we tested several additional compounds known to act on this pathway. Treatment with isobutylmethylxanthine, a nonspecific phosphodiesterase inhibitor, stimulated microneme secretion at 100 µM.2 However, treatment with forskolin, which elevates cyclic AMP in T. gondii (30), 8-bromo-cyclic-AMP (also expected to increase cyclic AMP), and 8-bromo-cyclic GMP (expected to increase cyclic GMP) had no effect on microneme secretion.2

Ethanol Increases Parasite IP3-- Ethanol is a potent trigger of microneme secretion in the absence of host cells (11). Because the effects of ethanol correlate with increases in parasite [Ca2+]i, we were interested in determining whether the second messenger IP3 was generated. Parasite IP3 was measured using a commercially available radioreceptor assay. A rapid increase in IP3 was observed after addition of 1% (171 mM) ethanol to extracellular tachyzoites at 37 °C (Fig. 3A). Peak IP3 levels were reached within the first minute after secretagogue addition in three independent experiments, with a mean maximal fold increase of 2.27 ± 1.31 compared with 0.84 ± 0.48 for the buffer-treated control. In parallel, secretion of microneme proteins was assayed by Western blot (Fig. 3B). IP3 release often preceded secretion of micronemal proteins, which is consistent with its signaling activity mediating stimulation of Ca2+ release from intracellular stores.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   Ethanol increases T. gondii IP3. A, tachyzoite IP3 levels were monitored by radioreceptor assay at intervals following the addition of 1% (171 mM) ethanol (+EtOH) or in control cells (-CTL) as described under "Experimental Procedures." Ethanol caused a transient increase in parasite IP3 after its addition. B, Western blot of parasite protein pellets obtained after IP3 extraction. Secreted MIC2 (sMIC2) is visible after 1.5 min, while levels of the cellular form (cMIC2) are unchanged. Both kinetic in A and Western blot in B are representative of three independent experiments, which showed similar results.

IP3 Receptor Antagonist Inhibits Attachment, Invasion, and Microneme Secretion-- The possibility that Toxoplasma contains intracellular Ca2+ release channels of the IP3/ryanodine receptor family prompted us to examine additional drugs that could block invasion and microneme secretion through modulation of Ca2+ channels. Xestospongin C is a membrane-permeable IP3 receptor antagonist that does not affect IP3 binding in rabbit cerebellar microsomes (31). Tachyzoites were pretreated with xestospongin C at doses from 10 to 0.1 µM before stimulation with ethanol or caffeine. Secretion induced by ethanol and caffeine was reduced upon treatment with >1 µM xestospongin C, as were the basal levels of secretion (Fig. 4B). In agreement with these results, Ca2+ release by addition of either caffeine (Fig. 4C) or ethanol (Fig. 4D) was reduced upon treatment with xestospongin C (Fig. 4, C and D). We also tested xestospongin C in attachment and invasion assays on host cells. In parallel, tachyzoites were pretreated with different drug concentrations before addition to host cells for 20 min. Attachment assays were performed on formaldehyde-fixed host cells for the same length of time. Xestospongin C inhibited both attachment and invasion in a dose-dependent manner with an approximate IC50 of 2 µM for attachment and 8 µM for invasion (Fig 4A). Treatment of fura-2/AM-loaded parasites with 1 µM xestospongin C reduced the increase in [Ca2+]i upon stimulation with caffeine (Fig 4C) and ethanol (Fig 4D), paralleling the inhibition of microneme secretion observed with this dose in Fig. 4B. Collectively, these studies show that xestospongin C is an antagonist of Ca2+-mediated microneme secretion, attachment, and invasion in T. gondii.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Xestospongin C inhibits microneme secretion, attachment, and invasion. A, xestospongin C caused a dose-dependent inhibition of attachment to and invasion of host cells. Values are the means + S.E. of three independent experiments, each with quadruplicate samples. B, Western blot of parasite supernatants compared with diluted lysates of parasite cell standards (cell stds) after treatment with xestospongin C (Xest C) followed by stimulation with 1% (171 mM) ethanol or 1 mM caffeine. 10 µM xestospongin C inhibited ethanol, caffeine, and basal (-) stimulation of MIC2 and MIC4. Westerns were performed as described in the legend to Fig. 1, with parasite actin detected using a rabbit anti-TgACT1 polyclonal antibody to monitor inadvertent lysis. C, D, xestospongin C inhibited stimulation of [Ca2+]i. Tachyzoites loaded with fura-2/AM were preincubated in buffer A for 3 min in the presence of Me2SO or 1 µM xestospongin C (XestC); traces were made in the presence of 1 mM CaCl2. C, the arrow indicates the addition of 1 mM caffeine (CAFF). D, the arrow indicates the addition of 100 mM (0.58%) ethanol (EtOH).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Calcium-mediated exocytosis of T. gondii microneme proteins is a key step in the invasion of host cells. The control of intracellular Ca2+ levels in T. gondii is not well characterized, prompting our search for modulators of secretion whose target was well studied in other Ca2+ signaling systems. We identified ryanodine and caffeine, two ryanodine receptor agonists, as stimuli of Ca2+-mediated microneme secretion. We also found that the second messenger IP3 was induced upon ethanol stimulation of parasites. Finally, the IP3 receptor antagonist xestospongin C inhibited the caffeine- and ethanol-induced increases in [Ca2+]i, as well as preventing microneme secretion, attachment, and invasion. Together, these results strongly suggest that channels of the IP3/ryanodine receptor superfamily in T. gondii mediate increases in [Ca2+]i, which in turn promote microneme secretion.

Ryanodine is an active component of the botanical insecticide ryania, an alkaloid found in the shrub Ryania speciosa. Ryanodine has potent effects on a variety of multicellular organisms (25). Receptors that release calcium from intracellular stores in response to ryanodine treatment have been described in vertebrates, where they usually are expressed in specialized neurosecretory or muscle cells (15). Ryanodine receptors also exist in a variety of invertebrates including crustaceans, insects, and worms; however, they have not been described in unicellular organisms (32). At micromolar levels ryanodine stabilizes ryanodine receptors in the open form, allowing Ca2+ liberation from the sarco-endoplasmic lumen (26). At higher concentrations, ryanodine receptor channels in rabbit skeletal sarcoplasmic reticulum vesicles are persistently blocked (33). We observed a similar biphasic dose response in T. gondii, and ryanodine stimulation of microneme secretion was dependent on both intracellular and extracellular calcium. Ryanodine stimulation of [Ca2+]i release has been shown to require extracellular calcium as part of its Ca2+-induced Ca2+ release mechanism, suggesting it may activate flux through plasma membrane channels and capacitative entry (17, 26). The induction of calcium release in T. gondii treated with ryanodine parallels that in well studied systems, suggesting the existence of ryanodine-responsive calcium channels in this early branching eukaryote.

Caffeine also induced microneme secretion by T. gondii, and was effective at doses that are 100-fold lower than its activity on mammalian cells. Unlike ryanodine, caffeine did not require extracellular Ca2+, a result similar to that reported for rat PC12 cells (35). In addition to acting on ryanodine-like calcium channels, caffeine and related alkylxanthines have been shown to inhibit cyclic nucleotide phosphodiesterases (25, 26, 33). The resulting increases in cyclic AMP and activation of protein kinase A can give rise to an increase in [Ca+2]i in mammalian cells (36). Although isobutylmethylxanthine, a nonselective phosphodiesterase inhibitor, also stimulated microneme secretion by T. gondii, two drugs expected to directly increase cyclic AMP, forskolin and 8-bromo-cyclic AMP, had no affect on microneme secretion. Similarly, treatment of parasites with 8-bromo-cyclic GMP did not affect microneme secretion. Thus, while we cannot rule out possible inhibition of phosphodiesterases, the effect of caffeine in elevating [Ca2+]i in T. gondii does not seem to be due to this mechanism. A third possible mode of action is that caffeine may inhibit the sarco-endoplasmic reticulum type ATPase involved in refilling calcium stores. This would be consistent with the results showing a more sustained [Ca2+]i elevation with caffeine than with ryanodine in the absence of extracellular Ca2+ (Fig. 2B). While this pump is not yet characterized in T. gondii, studies in the ciliate Paramecium tetraurelia have shown that the sarco-endoplasmic reticulum ATPase is exquisitely sensitive to caffeine inhibition (37). Ciliates are phylogenetically close relatives of the Apicomplexa. Determination of whether this mechanism for caffeine also operates in T. gondii and related parasites will require further study.

Unlike paramecium, the [Ca2+]i pool in T. gondii is sensitive to thapsigargin (12); however, ethanol stimulation of thapsigargin-pretreated parasites generates an additional increase in [Ca2+]i (11), implying that they also possess a thapsigargin-insensitive [Ca2+]i pool. Similarly, pretreatment with thapsigargin prior to stimulation with caffeine or ryanodine did not inhibit microneme secretion (data not shown), suggesting that this same thapsigargin-insensitive pool may be stimulated by caffeine or ryanodine.

Our studies demonstrate that IP3 acts as a second messenger during the stimulation of tachyzoites with ethanol, a known Ca2+-mediated trigger of microneme secretion (11). In higher eukaryotes, IP3 induces calcium release from channels located in the sarco-endoplasmic reticulum in a variety of cell types (38). Typically, IP3 is produced along with diacylglycerol after hydrolysis of phosphatidylinositol 4,5-bisphosphate by inositol phospholipid-specific phospholipase C (PLC). In higher eukaryotes, this process is mediated by PLC-gamma signaling through tyrosine kinase receptors and PLC-beta activated via heterotrimeric G-proteins (39). Comparisons of PLC isoforms delta , gamma , and beta  suggest that PLC-delta was present in single-celled eukaryotes, while the beta  and gamma  forms arose after the development of multicellular organisms ~940 million years ago (40). Consequently, parasites likely contain only the ancestral PLC-delta isoform. Consistent with this idea, T. cruzi contains a PLC-delta isoform (41) and PLC-delta candidate sequences are present in the Plasmodium falciparum and Plasmodium vivax genomes (42). While not conventionally associated with Ca2+ signaling, PLC-delta has recently been linked to Ca2+ transients associated with fertilization in mice (43). Thus, it is possible that PLC-delta plays an important role in protozoan calcium regulation.

Previous evidence for IP3-responsive Ca2+ release channels in unicellular organisms has been indirect. Entamoeba histolytica crude membranes bind radiolabeled IP3 (44), and a cross-reacting IP3 receptor antibody detects an appropriately sized protein in the ciliate Blepharisma japonicum (45, 46). Combined with the present findings, these results indicate that single-celled eukaryotes also likely have intracellular calcium release channels that respond to IP3. However, our attempts to identify IP3 or ryanodine receptor channels in T. gondii using a cross-reactive antibody (mouse monoclonal antibody 34C anti-chicken ryanodine receptor) (47) have not been successful. IP3 and ryanodine receptors are ~40% homologous between Caenorhabditis elegans and vertebrates, and they are likely to be significantly more divergent in protozoa due to their early branching phylogenetic position (48). We have analyzed the nearly complete genomes of P. falciparum (42) and Cryptosporidium parvum (www.parvum.mic.vcu.edu/) and the Apicomplexan expressed sequence tag databases (paradb.cis.upenn.edu/) and found that these organisms do not contain well recognized motifs for IP3 or ryanodine receptors such as SPRY and MIR domains. Consequently, it is likely that protozoa such as T. gondii possess intracellular calcium release channels that are unconventional in sequence and/or function.

Our observations suggest that IP3 catalyzes [Ca2+]i release in the parasite through an intracellular channel related to the IP3 ryanodine receptor superfamily during T. gondii invasion of host cells. To test whether production of IP3 was necessary for microneme secretion and host cell attachment, we utilized xestospongin C, a compound that inhibits IP3-dependent Ca2+ release from rat cerebellar microsomes (31) and Dictyostelium vesicles (34). Xestospongin C acts primarily as a competitive inhibitor of IP3 to block calcium release from IP3 receptors; however, it can also inhibit ryanodine receptors with somewhat lower potency (31). Xestospongin C treatment of T. gondii inhibited ethanol- and caffeine-mediated secretion of micronemes and prevented attachment and invasion of host cells. Together, these results imply that xestospongin C inhibits microneme secretion by modulating a T. gondii [Ca2+]i release channel that responds to IP3. These findings suggest that the engagement of natural ligands during host cell invasion may also give rise to IP3 to promote the observed increases in [Ca2+]i in the parasite reported previously (10).

The results of our studies using Ca2+ release channel agonists and antagonists strongly suggest that the protozoan parasite T. gondii possess intracellular calcium release channels of the IP3/ryanodine superfamily. Relatively low concentrations of caffeine, ryanodine, and xestospongin C affected microneme release, indicating that protozoa may be unusually sensitive to these agents that affect calcium channels. While we cannot rule out secondary effects on other pathways, the primary response observed to all these compounds is consistent with their acting on a calcium release channel. A model integrating our findings with a hypothetical signaling cascade is presented in Fig. 5. We show that ethanol increases IP3 production, a second messenger that could act to liberate the [Ca2+]i pool. We also show that ryanodine increases [Ca2+]i, suggesting it interacts directly with a putative [Ca2+]i release channel via a Ca2+-induced Ca2+ release mechanism. The calcium-dependent stimulation of microneme secretion by ryanodine, caffeine, or ethanol was thapsigargin-insensitive, indicating that this unique pool may be responsible for calcium signaling in parasites. During contact with host cells, it is likely that a similar cascade is triggered to release Ca2+ from an intracellular store and stimulate microneme secretion. A role for a putative parasite PLC in the conversion of phosphatidylinositol bisphosphate to IP3 and diacylglycerol is suggested by the available data but has not yet been directly demonstrated. The responsiveness to both IP3 and ryanodine suggests that calcium release channels may exist as two separate entities. However, we have not excluded the intriguing possibility that protozoa possess a single ancient channel displaying hybrid properties of both. Analysis of calcium channels in protozoa will be illuminating to studies of the function and evolution of eukaryotic calcium signaling proteins.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Proposed model for intracellular calcium signaling in T. gondii. Stimulation of a parasite signaling cascade during treatment with ethanol or contact with host cells leads to second messenger IP3 formation, increases in [Ca2+]i via a calcium release channel, and microneme secretion. The releasable store of calcium was not sensitive to thapsigargin, indicating that it may comprise a unique intracellular pool. IP3R, IP3 receptor.


    ACKNOWLEDGEMENTS

We thank Drs. Steve Beverley, Vern Carruthers, Dan Goldberg, Andy Pekosz, Paul Schlessinger, and Tom Steinberg for advice and critical input and Jeff Diffenderfer for expert technical assistance.

    FOOTNOTES

* This work was partially supported by National Institutes of Health Grants 34036 (to L. D. S.) and AI43614 (to S. N. J. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Partially supported by an Institutional Training Grant AI017172-19 to Washington University.

|| Recipient of a New Investigator Award in Molecular Parasitology from the Burroughs Wellcome Fund.

** Recipient of a Scholar Award from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Molecular Microbiology, Washington University School of Medicine, Box 8230, St. Louis, MO 63110. Tel.: 314-362-8873; Fax: 314-362-1232; E-mail: sibley@borcim.wustl.edu.

Published, JBC Papers in Press, May 13, 2002, DOI 10.1074/jbc.M202553200

2 J. L. Lovett and L. D. Sibley, unpublished data.

    ABBREVIATIONS

The abbreviations used are: IP3, D-myo-inositol 1,4,5-triphosphate; BAPTA-AM, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N-tetraacetic acid tetra(acetoxymethyl) ester; PLC, phosphoinositol-specific phospholipase C; RYA, ryanodine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Carruthers, V. B., and Sibley, L. D. (1997) Eur. J. Cell Biol. 73, 114-123[Medline] [Order article via Infotrieve]
2. Tomley, F. M., and Soldati, D. S. (2001) Trends Parasitol. 17, 81-88[CrossRef][Medline] [Order article via Infotrieve]
3. Soldati, D., Dubremetz, J. F., and Lebrun, M. (2001) Int. J. Parasitol. 31, 1293-1302[CrossRef][Medline] [Order article via Infotrieve]
4. Garcia-Réguet, N., Lebrun, M., Fourmaux, N., Mercereau-Puijalon, O., Mann, T., Beckers, C. J. M., Samyn, B., Van Beeumen, J., Bout, D., and Dubremetz, J. (2000) Cell. Microbiol. 2, 353-364[CrossRef][Medline] [Order article via Infotrieve]
5. Fourmaux, M. N., Achbarou, A., Mercereau-Puijalon, O., Bderre, C., Brache, I., Loyens, A., Odberg-Ferragut, C., Camus, D., and Dubremetz, J. F. (1996) Mol. Biochem. Parasitol. 83, 201-210[CrossRef][Medline] [Order article via Infotrieve]
6. Brecht, S., Carruthers, V. B., Ferguson, D. J., Giddings, O. K., Wang, G., Jakle, U., Harper, J. M., Sibley, L. D., and Soldati, D. (2001) J. Biol. Chem. 276, 4119-4127[Abstract/Free Full Text]
7. Carruthers, V. B., Håkansson, S., Giddings, O. K., and Sibley, L. D. (2000) Infect. Immun. 68, 4005-4011[Abstract/Free Full Text]
8. Vieira, M. C., and Moreno, S. N. (2000) Mol. Biochem. Parasitol. 106, 157-162[CrossRef][Medline] [Order article via Infotrieve]
9. Carruthers, V. B., Giddings, O. K., and Sibley, L. D. (1999) Cell. Microbiol. 1, 225-236[CrossRef][Medline] [Order article via Infotrieve]
10. Carruthers, V. B., and Sibley, L. D. (1999) Mol. Microbiol. 31, 421-428[CrossRef][Medline] [Order article via Infotrieve]
11. Carruthers, V. B., Moreno, S. N. J., and Sibley, L. D. (1999) Biochem. J. 342, 379-386[Medline] [Order article via Infotrieve]
12. Moreno, S. N. J., and Zhong, L. (1996) Biochem. J. 313, 655-659[Medline] [Order article via Infotrieve]
13. Pingret, L., Millot, J. M., Sharonov, S., Bonhomme, A., Manfait, M., and Pinon, J. M. (1996) J. Histochem. Cytochem. 44, 1123-1129[Abstract]
14. Brunger, A. T. (2000) Curr. Opin. Neurobiol. 10, 293-302[CrossRef][Medline] [Order article via Infotrieve]
15. Sorrentino, V., Barone, V., and Rossi, D. (2000) Curr. Opin. Genet. Dev. 10, 662-667[CrossRef][Medline] [Order article via Infotrieve]
16. Guse, A. H. (1999) Cell. Signal. 11, 309-316[CrossRef][Medline] [Order article via Infotrieve]
17. Putney, J. W., Jr. (1990) Cell Calcium 11, 611-624[CrossRef][Medline] [Order article via Infotrieve]
18. Calvert, C. M., and Sanders, D. (1995) J. Biol. Chem. 270, 7272-7280[Abstract/Free Full Text]
19. Passos, A. P., and Garcia, C. R. (1998) Biochem. Biophys. Res. Commun. 245, 155-160[CrossRef][Medline] [Order article via Infotrieve]
20. Masuda, W., Takenaka, S., Tsuyama, S., Tokunaga, M., Yamaji, R., Inui, H., Miyatake, K., and Nakano, Y. (1997) Comp. Biochem. Physiol. C Pharmacol. Toxicol. 118, 279-283[CrossRef]
21. Marchesini, N., Bollo, M., Hernández, G., Garrido, M. N., and Machado-Domenech, E. E. (2002) Mol. Biochem. Parasitol. 120, 83-91[CrossRef][Medline] [Order article via Infotrieve]
22. Thiel, G., MacRobbie, E. A. C., and Hanke, D. E. (1990) EMBO J. 9, 1737-1741[Medline] [Order article via Infotrieve]
23. Morisaki, J. H., Heuser, J. E., and Sibley, L. D. (1995) J. Cell Sci. 108, 2457-2464[Abstract]
24. Wan, K. L., Carruthers, V. B., Sibley, L. D., and Ajioka, J. W. (1997) Mol. Biochem. Parasitol. 84, 203-214[CrossRef][Medline] [Order article via Infotrieve]
25. Dobrowolski, J. M., and Sibley, L. D. (1996) Cell 84, 933-939[CrossRef][Medline] [Order article via Infotrieve]
26. Zucchi, R., and Ronca-Testoni, S. (1997) Pharmacol. Rev. 49, 1-51[Abstract/Free Full Text]
27. Carruthers, V. B., Sherman, G. D., and Sibley, L. D. (2000) J. Biol. Chem. 275, 14346-14353[Abstract/Free Full Text]
28. Wagner-Mann, C., Hu, Q., and Sturek, M. (1992) Br. J. Pharmacol. 105, 903-911[Medline] [Order article via Infotrieve]
29. Daly, J. W. (2000) J. Auton. Nerv. Syst. 81, 44-52[CrossRef][Medline] [Order article via Infotrieve]
30. Kirkman, L. A., Weiss, L. M., and Kim, K. (2001) Infect. Immun. 69, 148-153[Abstract/Free Full Text]
31. Gafni, J., Munsch, J. A., Lam, T. H., Catlin, M. C., Costa, L. G., Molinski, T. F., and Pessah, I. N. (1997) Neuron 19, 723-733[CrossRef][Medline] [Order article via Infotrieve]
32. Sutko, J. L., and Airey, J. A. (1996) Physiol. Rev. 76, 1027-1071[Abstract/Free Full Text]
33. Buck, E., Zimanyi, I., Abramson, J. J., and Pessah, I. N. (1992) J. Biol. Chem. 267, 23560-23567[Abstract/Free Full Text]
34. Schaloske, R., Schlatterer, C., and Malchow, D. (2000) J. Biol. Chem. 275, 8404-8408[Abstract/Free Full Text]
35. Koizumi, S., Lipp, P., Berridge, M. J., and Bootman, M. D. (1999) J. Biol. Chem. 274, 33327-33333[Abstract/Free Full Text]
36. Wayman, G. A., Hinds, T. R., and Storm, D. R. (1995) J. Biol. Chem. 270, 24108-24115[Abstract/Free Full Text]
37. Kissmehl, R., Huber, S., Kottwitz, B., Hauser, K., and Plattner, H. (1998) Cell Calcium 24, 193-203[CrossRef][Medline] [Order article via Infotrieve]
38. Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve]
39. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) Nat. Rev. Mol. Cell. Biol. 1, 11-21[CrossRef][Medline] [Order article via Infotrieve]
40. Koyanagi, M., Ono, K., Suga, H., Iwabe, N., and Miyata, T. (1998) FEBS Lett. 439, 66-70[CrossRef][Medline] [Order article via Infotrieve]
41. Furuya, T., Kashuba, C., Docampo, R., and Moreno, S. N. (2000) J. Biol. Chem. 275, 6428-6438[Abstract/Free Full Text]
42. Bahl, A., Brunk, B., Coppel, R. L., Crabtree, J., Diskin, S. J., Fraunholz, M. J., Grant, G. R., Gupta, D., Huestis, R. L., Kissinger, J. C., Labo, P., Li, L., McWeeney, S. K., Milgram, A. J., Roos, D. S., Schug, J., and Stoeckert, C. J., Jr. (2002) Nucleic Acids Res. 30, 87-90[Abstract/Free Full Text]
43. Fukami, K., Nakao, K., Inoue, T., Kataoka, Y., Kurokawa, M., Fissore, R. A., Nakamura, K., Katsuki, M., Mikoshiba, K., Yoshida, N., and Takenawa, T. (2001) Science 292, 920-923[Abstract/Free Full Text]
44. Raha, S., Dalal, B., Biswas, S., and Biswas, B. B. (1994) Mol. Biochem. Parasitol. 65, 63-71[CrossRef][Medline] [Order article via Infotrieve]
45. Fabczak, H., Walerczyk, M., Groszynska, G., and Fabczak, S. (1999) Photochem. Photobiol. 69, 254-258
46. Matsuoka, T., Moriyama, N., Kida, A., Okuda, K., Suzuki, T., and Kotsuki, H. (2000) J. Photochem. Photobiol. B. Biol. 54, 131-135[CrossRef][Medline] [Order article via Infotrieve]
47. Airey, J. A., Beck, C. F., Murakami, K., Tanksley, S. J., Deerinck, T. J., Ellisman, M. H., and Sutko, J. L. (1990) J. Biol. Chem. 265, 14187-14194[Abstract/Free Full Text]
48. Baldauf, S. L., Roger, A. J., Wenk-Siefert, I., and Doolittle, W. F. (2000) Science 290, 972-977[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Sci SignalHome page
A. H. Guse
Back from the Dormant Stage: Second Messenger Cyclic ADP-Ribose Essential for Toxoplasma gondii Pathogenicity
Sci. Signal., April 29, 2008; 1(17): pe18 - pe18.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Nagamune, S. N. J. Moreno, and L. D. Sibley
Artemisinin-Resistant Mutants of Toxoplasma gondii Have Altered Calcium Homeostasis
Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3816 - 3823.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
K. Nagamune, W. L. Beatty, and L. D. Sibley
Artemisinin Induces Calcium-Dependent Protein Secretion in the Protozoan Parasite Toxoplasma gondii
Eukaryot. Cell, November 1, 2007; 6(11): 2147 - 2156.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. F. Teo, X. W. Zhou, M. Bogyo, and V. B. Carruthers
Cysteine Protease Inhibitors Block Toxoplasma gondii Microneme Secretion and Cell Invasion
Antimicrob. Agents Chemother., February 1, 2007; 51(2): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E.-M. Ladenburger, I. Korn, N. Kasielke, T. Wassmer, and H. Plattner
An Ins(1,4,5)P3 receptor in Paramecium is associated with the osmoregulatory system
J. Cell Sci., September 1, 2006; 119(17): 3705 - 3717.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
K. Nagamune and L. D. Sibley
Comparative Genomic and Phylogenetic Analyses of Calcium ATPases and Calcium-Regulated Proteins in the Apicomplexa
Mol. Biol. Evol., August 1, 2006; 23(8): 1613 - 1627.
[Abstract] [Full Text] [PDF]


Home page<